Outcomes following KRASG12C inhibitor treatment in patients with KRASG12C-mutated solid tumors: A systematic review and meta-analysis

Objective: To assess the efficacy and safety of FDA-approved KRASG12C inhibitors in patients with KRASG12C-mutated solid tumors. Methods: We searched PubMed, EMBASE, Cochrane Library, and major international conferences for clinical trials published in English up to March 6, 2023. Clinical trials in...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Qi-An Chen (Author), Wei-Hao Lin (Author), Xiao-Xiang Zhou (Author), Zheng Cao (Author), Xiao-Li Feng (Author), Yi-Bo Gao (Author), Jie He (Author)
Format: Knjiga
Izdano: Elsevier, 2024-02-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!

Internet

Connect to this object online.

3rd Floor Main Library

Podrobnosti zaloge 3rd Floor Main Library
Signatura: A1234.567
Kopija 1 Prosto